FDA to require vision loss warning on GLP-1 drug labels
mediastack
2026-11-10 21:00
FDA to require vision loss warning on GLP-1 drug labels
The labelling requirement stems from the findings of a 2024 study and subsequent FDA trials that tested the results of that study.

https://globalnews.ca/news/12144337/glp1-vision-loss-warning-fda/

#globalmontreal
Göm kommentarerna Kommentarer (0)

Du måste logga in före du kommenterar